Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
GDRX
↓ PDF (Pro)GoodRx Holdings Inc. Class A Common Stock
HealthcareHealth Information ServicesUnited StatesNASDAQ
$2.52
+0.80%today
MKT CAP
$884M
+13.5% · 1Y
Earnings History
-9.2%
-12.3%
-1.7%
-2.2%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$2.52
Low
$2.00
Analyst Mean
$2.99
High
$3.50
13 analystsHold
Full Financials
Trailing P/E28.0x
Forward P/E6.8x
EV/EBITDA11.4x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-4.4%
Earnings Growth YoY-88.3%
Revenue Growth QoQ-0.4%
5y Revenue CAGR+1.3%
5y Earnings CAGR-
Gross Margin91.8%
Operating Margin7.2%
Net Margin2.6%
ROE3.2%
Debt / Equity87.04x
Free Cash Flow$90M
Insider Ownership13.0%
Institutional Ownership63.6%
Short % of Float8.55%
Days to Cover5.5d
1 Week+7.7%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BARNES WENDY LYNN | Chief Executive Officer | Other | 277,288 | - | - | 2026-04-15 |
| MCGINNIS CHRISTOPHER ALAN | Chief Financial Officer | Stock | 36,987 | $0.00 | $0.00M | 2026-04-15 |
| MCGINNIS CHRISTOPHER ALAN | Chief Financial Officer | Conversion | 36,987 | $2.32 | $0.09M | 2026-04-15 |
| REY-GIRAUD AGNES | Director | Stock | 75,219 | $0.00 | $0.00M | 2026-03-12 |
| REY-GIRAUD AGNES | Director | Conversion | 192,185 | $0.47 | $0.09M | 2026-03-12 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Francisco Partners Management, LP | institution | 57.38% | $0.18B | +0.00% | 2025-12-31 |
| Vanguard Group Inc | institution | 9.15% | $0.03B | +4.09% | 2025-12-31 |
| Silver Lake Group, LLC | institution | 3.37% | $0.01B | +0.00% | 2025-12-31 |
| Ameriprise Financial, Inc. | institution | 3.13% | $0.01B | -15.77% | 2025-12-31 |
| Renaissance Technologies, LLC | institution | 3.07% | $0.01B | -7.45% | 2025-12-31 |
| Petrus Trust Company, LTA | institution | 2.96% | $0.01B | +0.00% | 2025-12-31 |
| LSV Asset Management | institution | 2.70% | $0.01B | +20.02% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.61% | $0.01B | -0.29% | 2025-12-31 |
| Dimensional Fund Advisors LP | institution | 2.34% | $0.01B | -7.52% | 2026-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | fund | 2.06% | $0.01B | +8.35% | 2025-12-31 |
| Prescott Group Capital Management, L.L.C. | institution | 2.01% | $0.01B | +18.59% | 2026-03-31 |
| Blackrock Inc. | institution | 1.89% | $0.01B | +0.45% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | fund | 1.33% | $0.00B | +9.26% | 2025-12-31 |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund | fund | 1.21% | $0.00B | +0.00% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.97% | $0.00B | +2.48% | 2025-12-31 |
| Pacer Funds Trust-Pacer US Small Cap Cash Cows 100 ETF | fund | 0.74% | $0.00B | -5.80% | 2026-01-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.66% | $0.00B | +38.05% | 2026-02-28 |
| Victory Portfolios II-VictoryShares Small Cap Free Cash Flow ETF | fund | 0.51% | $0.00B | +132.98% | 2025-12-31 |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Targeted Value Portfolio | fund | 0.51% | $0.00B | +0.00% | 2026-01-31 |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | fund | 0.44% | $0.00B | +9.41% | 2026-02-28 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| TALK | $870M | 24 | 129.8 | 23.6 | - | - | - | - | 0.00% |
| SDGR | $925M | 18 | - | - | - | -30.1% | 55% | 34.13 | 0.00% |
| OMDA | $940M | 20 | - | 44.2 | - | - | - | - | 0.00% |
| CERT | $948M | 80 | - | 12.6 | 11.4 | -0.1% | 62% | 28.96 | 0.00% |
| HSTM | $677M | 40 | 35.1 | 27.4 | - | - | - | - | 56.00% |
| TDOC | $1.2B | 28 | - | - | 31.9 | -12.4% | 69% | 77.68 | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for GDRX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.